Serial NT-proBNP measurements demonstrate superior predictive value over single assessments for forecasting cardiovascular mortality or heart failure hospitalization in patients with coronary artery disease and T2DM (42). This evidence concerns the gene NPPB and type 2 diabetes mellitus.